News & Events



BD Names J. Peter Natale as Chief Information Officer


Contact: Colleen T. White
Corporate Communications
(201) 847-5369
Email: colleen_white@bd.com

Patricia A.  Spinella
Investor Relations
(201) 847-5453
Email: patricia_spinella@bd.com

Franklin Lakes, NJ (June 14, 2004) -- BD (Becton, Dickinson and Company) (NYSE:BDX) today announced that J. Peter Natale has been named Vice President and Chief Information Officer.

"We are very pleased that Pete is joining BD in this critical role and will lead the management of our global IT operations," said John R. Considine, Executive Vice President and Chief Financial Officer. "His nearly two decades of experience in global enterprise-wide business process and systems implementation and transformation will be of great benefit to our Company."

In his role at BD, Mr. Natale will report to Mr. Considine and will become a member of the BD Leadership Team. He will have overall responsibility for BD's global IT operations.

Mr. Natale joins BD from the General Electric Company, where he served most recently as the Americas IT Leader for GE Consumer & Industrial, a $9 billion business unit. Previously, he served as CIO for GE's Electrical Products and Power Equipment businesses. Prior to joining GE, Mr. Natale served for 12 years at Westvaco Corporation in a variety of IT positions of increasing responsibility within commercial analysis, finance and manufacturing.

As a three-time graduate of the University of Connecticut, Mr. Natale remains an active member of the university community through his participation with its Board of Advisors.

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2003, BD reported total revenues of $4.528 billion.



This press release may contain certain forward-looking statements (as defined under Federal securities laws) regarding BD's performance, including future revenues, products and income, or events or developments that BD expects to occur or anticipates occurring in the future. All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Factors that could cause actual results to vary materially from any forward-looking statement include, but are not limited to: competitive factors; pricing and market share pressures; uncertainties of litigation; BD's ability to achieve sales and earnings forecasts, which are based on sales volume and product mix assumptions, to achieve its cost savings objectives, and to achieve anticipated synergies and other cost savings in connection with acquisitions; changes in regional, national or foreign economic conditions; increases in energy costs; fluctuations in costs and availability of raw materials and in BD's ability to maintain favorable supplier arrangements and relationships; changes in interest or foreign currency exchange rates; delays in product introductions; and changes in health care or other governmental regulation, as well as other factors discussed in this press release and in BD's filings with the Securities and Exchange Commission. We do not intend to update any forward-looking statements.

 

Unless otherwise noted, BD, BD logo and all other trademarks are property of Becton Dickinson and Company. © 2013 BD